- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 24
  num_fold: 3874
  S: 3069
  I: 721
  R: 84
  median_fold: 1.9
  percent: 5.4
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 21
  num_fold: 1048
  S: 790
  I: 222
  R: 36
  median_fold: 2.5
  percent: 1.5
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 164
  num_fold: 17677
  S: 12790
  I: 3912
  R: 975
  median_fold: 2.5
  percent: 24.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 39
  num_fold: 2248
  S: 1486
  I: 681
  R: 81
  median_fold: 2.9
  percent: 3.1
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 52
  num_fold: 3810
  S: 2397
  I: 1163
  R: 250
  median_fold: 3.8
  percent: 5.3
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 6
  num_fold: 171
  S: 119
  I: 43
  R: 9
  median_fold: 3.8
  percent: 0.24
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.21
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.019
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 63
  num_fold: 8249
  S: 5786
  I: 2138
  R: 325
  median_fold: 3.6
  percent: 11.0
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 8
  num_fold: 354
  S: 250
  I: 84
  R: 20
  median_fold: 3.1
  percent: 0.49
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 17
  num_fold: 2665
  S: 2200
  I: 443
  R: 22
  median_fold: 3.1
  percent: 3.7
  priority: 2
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 8
  num_fold: 838
  S: 408
  I: 177
  R: 253
  median_fold: 6.3
  percent: 1.2
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 43
  S: 41
  I: 2
  R: 0
  median_fold: 2.1
  percent: 0.06
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 34
  num_fold: 1949
  S: 1198
  I: 523
  R: 228
  median_fold: 4.0
  percent: 2.7
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 11
  num_fold: 310
  S: 250
  I: 57
  R: 3
  median_fold: 1.5
  percent: 0.43
  priority: 3
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 342
  S: 96
  I: 246
  R: 0
  median_fold: 6.8
  percent: 0.47
  priority: 3
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 318
  S: 213
  I: 101
  R: 4
  median_fold: 1.7
  percent: 0.44
  priority: 5
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 499
  S: 100
  I: 398
  R: 1
  median_fold: 20.0
  percent: 0.69
  priority: 5
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 0.66
  priority: 6
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 172
  S: 152
  I: 0
  R: 20
  median_fold: 2.4
  percent: 0.24
  priority: 6
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 134
  S: 134
  I: 0
  R: 0
  median_fold: 4.3
  percent: 0.19
  priority: 7
- vaccine: CoronaVac
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 70
  S: 2
  I: 68
  R: 0
  median_fold: 8.0
  percent: 0.097
  priority: 7
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 15
  num_fold: 1824
  S: 1259
  I: 551
  R: 14
  median_fold: 3.2
  percent: 2.5
  priority: 7
- vaccine: CoronaVac
  dosage: 2.0
  infection: infected
  num_ref_name: 6
  num_fold: 214
  S: 106
  I: 68
  R: 40
  median_fold: 5.4
  percent: 0.3
  priority: 7
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 7
  num_fold: 912
  S: 425
  I: 487
  R: 0
  median_fold: 5.1
  percent: 1.3
  priority: 7
- vaccine: CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 404
  S: 253
  I: 151
  R: 0
  median_fold: 3.6
  percent: 0.56
  priority: 7
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 166
  S: 110
  I: 43
  R: 13
  median_fold: 2.6
  percent: 0.23
  priority: 8
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 64
  S: 40
  I: 24
  R: 0
  median_fold: 2.0
  percent: 0.089
  priority: 10
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 568
  S: 396
  I: 130
  R: 42
  median_fold: 4.0
  percent: 0.79
  priority: 11
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 20
  num_fold: 1260
  S: 849
  I: 343
  R: 68
  median_fold: 2.9
  percent: 1.7
  priority: 12
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 7
  num_fold: 180
  S: 130
  I: 44
  R: 6
  median_fold: 2.6
  percent: 0.25
  priority: 12
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 6
  num_fold: 418
  S: 223
  I: 179
  R: 16
  median_fold: 4.9
  percent: 0.58
  priority: 12
- vaccine: KCONVAC
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 251
  S: 241
  I: 10
  R: 0
  median_fold: 1.2
  percent: 0.35
  priority: 17
- vaccine: Convidecia
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 215
  S: 215
  I: 0
  R: 0
  median_fold: 1.4
  percent: 0.3
  priority: 18
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 317
  S: 76
  I: 238
  R: 3
  median_fold: 7.7
  percent: 0.44
  priority: 26
- vaccine: mRNA-1273 + mRNA-1273.351
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 237
  S: 222
  I: 11
  R: 4
  median_fold: 2.2
  percent: 0.33
  priority: 28
- vaccine: mRNA-1273 + mRNA-1273.211
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 4840
  S: 4808
  I: 32
  R: 0
  median_fold: 2.7
  percent: 6.7
  priority: 29
- vaccine: AZD1222 + Sputnik V
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 76
  S: 0
  I: 76
  R: 0
  median_fold: 9.5
  percent: 0.11
  priority: 32
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 142
  S: 42
  I: 82
  R: 18
  median_fold: 6.6
  percent: 0.2
  priority: 34
- vaccine: Ad26.COV2.S + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 270
  S: 135
  I: 135
  R: 0
  median_fold: 5.4
  percent: 0.37
  priority: 35
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 7
  num_fold: 491
  S: 372
  I: 113
  R: 6
  median_fold: 1.6
  percent: 0.68
  priority: 36
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 62
  S: 6
  I: 56
  R: 0
  median_fold: 7.5
  percent: 0.086
  priority: 38
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 6
  S: 6
  I: 0
  R: 0
  median_fold: 0.65
  percent: 0.0083
  priority: 38
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 170
  S: 86
  I: 84
  R: 0
  median_fold: 4.8
  percent: 0.24
  priority: 38
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 9
  num_fold: 609
  S: 324
  I: 164
  R: 121
  median_fold: 1.8
  percent: 0.84
  priority: 43
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 3
  num_fold: 42
  S: 29
  I: 10
  R: 3
  median_fold: 3.0
  percent: 0.058
  priority: 43
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 382
  S: 208
  I: 174
  R: 0
  median_fold: 4.8
  percent: 0.53
  priority: 43
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 177
  S: 166
  I: 11
  R: 0
  median_fold: 2.5
  percent: 0.25
  priority: 44
- vaccine: AZD1222 + mRNA
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 60
  S: 0
  I: 52
  R: 8
  median_fold: 9.4
  percent: 0.083
  priority: 49
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: infected
  num_ref_name: 8
  num_fold: 814
  S: 639
  I: 114
  R: 61
  median_fold: 2.2
  percent: 1.1
  priority: 1000
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: infected
  num_ref_name: 4
  num_fold: 358
  S: 271
  I: 79
  R: 8
  median_fold: 2.8
  percent: 0.5
  priority: 1000
